Preliminary trial of aminoglutethimide in breast cancer.
D015065:17-Hydroxycorticosteroids / Q000652:urine; D015068:17-Ketosteroids / Q000652:urine; D000284:Administration, Oral; D000616:Aminoglutethimide / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001859:Bone Neoplasms / Q000188:drug therapy; D001943:Breast Neoplasms / Q000188:drug therapy* / Q000652:urine; D002369:Castration; D002490:Central Nervous System / Q000187:drug effects; D003907:Dexamethasone / Q000627:therapeutic use; D004967:Estrogens / Q000652:urine; D005260:Female; D005438:Fludrocortisone / Q000627:therapeutic use; D006801:Humans; D009362:Neoplasm Metastasis; D010053:Ovary; D012075:Remission, Spontaneous; D012878:Skin Neoplasms / Q000188:drug therapy
D015065:17-Hydroxycorticosteroids; D015068:17-Ketosteroids; D000970:Antineoplastic Agents; D004967:Estrogens; D000616:Aminoglutethimide; D003907:Dexamethasone; D005438:Fludrocortisone